Patel SD, Mitchell EG. HYPERPARATHYROIDISM-INDUCED ERYTHROPOIETIN RESISTANCE: IMPLICATIONS FOR CKD MANAGEMENT. IRJPS [Internet]. 2023 Oct. 19 [cited 2025 Sep. 9];8(3):1-8. Available from: https://zapjournals.com/Journals/index.php/Pharmaceutical/article/view/1198